Dr. Merjaneh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6701 Fannin St
Houston, TX 77030
Education & Training
Emory University School of MedicineFellowship, Pediatric Endocrinology, 2011 - 2014
University of Texas Health Science Center at HoustonResidency, Pediatrics, 2009 - 2011
University of Aleppo Faculty of MedicineClass of 2004
Certifications & Licensure
TX State Medical License 2023 - 2025
WA State Medical License 2014 - 2024
GA State Medical License 2011 - 2014- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes Start of enrollment: 2016 Dec 29
Publications & Presentations
PubMed
- 1 citationsRole of hyperglycemia in cystic fibrosis pulmonary exacerbations.Lina Merjaneh, Aniket R Sidhaye, Phuong T Vu, Sonya L Heltshe, Christopher H Goss
Journal of Cystic Fibrosis. 2023-09-01 - 4 citationsSystemic Corticosteroids in the Management of Pediatric Cystic Fibrosis Pulmonary Exacerbations.Chelsea S Davis, Anna V Faino, Frankline Onchiri, Ronald L Gibson, Lina Merjaneh
Annals of the American Thoracic Society. 2023-01-01 - The Frequency of Undiagnosed Celiac Disease in Youth with Type 1 Diabetes and Its Association with Diabetic Retinopathy: The SEARCH for Diabetes in Youth Study.Ryan P Brady, Elizabeth T Jensen, Joseph Rigdon, Nancy A Crimmins, Daniel Mallon
Pediatric Diabetes. 2023-01-01
Journal Articles
- Pediatric Case Series of Cystic Fibrosis, Diabetes, and Islet Cell AutoimmunityLina Merjaneh, MD, Diabetes Care
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
